Why the study?
What is the optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stents?
What is the optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stents?
Answers are grounded in this paper and cite their sources.
The optimal duration of dual antiplatelet therapy after PCI with drug-eluting stents remains unclear based on current clinical studies.
“To determine the optimal duration of dual antiplatelet therapy and the risk–benefit ratio for long-term dual antiplatelet therapy after drug-eluting stents, several clinical studies have been performed, but study findings are still equivocal.”
No takes yet. Share an insight, caveat, or question.
Park et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: